These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23360241)

  • 21. Colon-specific delivery of 5-aminosalicylic acid from chitosan-Ca-alginate microparticles.
    Mladenovska K; Raicki RS; Janevik EI; Ristoski T; Pavlova MJ; Kavrakovski Z; Dodov MG; Goracinova K
    Int J Pharm; 2007 Sep; 342(1-2):124-36. PubMed ID: 17590293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and sustained release of diatomite incorporated and Eudragit L100 coated hydroxypropyl cellulose/chitosan aerogel microspheres.
    Sang Y; Gao J; Han X; Liang T; Chen T; Zhao Y
    Int J Biol Macromol; 2024 May; 267(Pt 1):131447. PubMed ID: 38588843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of selected formulation variables on the preparation of enzyme-entrapped Eudragit S100 microspheres.
    Rawat M; Saraf S; Saraf S
    AAPS PharmSciTech; 2007 Dec; 8(4):E116. PubMed ID: 18181537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation and optimisation of lamivudine-loaded Eudragit
    Vilas S; Thilagar S
    IET Nanobiotechnol; 2021 Feb; 15(1):90-99. PubMed ID: 34694732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glutaraldehyde cross-linked chitosan microspheres for controlled delivery of zidovudine.
    Nayak UY; Gopal S; Mutalik S; Ranjith AK; Reddy MS; Gupta P; Udupa N
    J Microencapsul; 2009 May; 26(3):214-22. PubMed ID: 18819029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design of microencapsulated chitosan microspheres for colonic drug delivery.
    Lorenzo-Lamosa ML; Remuñán-López C; Vila-Jato JL; Alonso MJ
    J Control Release; 1998 Mar; 52(1-2):109-18. PubMed ID: 9685941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eudragit S-100 entrapped chitosan microspheres of valdecoxib for colon cancer.
    Thakral NK; Ray AR; Majumdar DK
    J Mater Sci Mater Med; 2010 Sep; 21(9):2691-9. PubMed ID: 20535630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eudragit® S100 coated calcium pectinate microspheres of curcumin for colon targeting.
    Zhang L; Cao F; Ding B; Li Q; Xi Y; Zhai G
    J Microencapsul; 2011; 28(7):659-67. PubMed ID: 21824069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulation optimization of double emulsification method for preparation of enzyme-loaded Eudragit S100 microspheres.
    Rawat M; Saraf S
    J Microencapsul; 2009 Jun; 26(4):306-14. PubMed ID: 18686142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and development of multiparticulate system for targeted drug delivery to colon.
    Chourasia MK; Jain SK
    Drug Deliv; 2004; 11(3):201-7. PubMed ID: 15204639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel interpenetrating network chitosan-poly(ethylene oxide-g-acrylamide) hydrogel microspheres for the controlled release of capecitabine.
    Agnihotri SA; Aminabhavi TM
    Int J Pharm; 2006 Nov; 324(2):103-15. PubMed ID: 16824710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
    Xu H; Zhong H; Liu M; Xu C; Gao Y
    Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation and evaluation of Eudragit S 100 microspheres as pH-sensitive release preparations for piroxicam and theophylline using the emulsion-solvent evaporation method.
    Obeidat WM; Price JC
    J Microencapsul; 2006 Mar; 23(2):195-202. PubMed ID: 16754375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eudragit-coated dextran microspheres of 5-fluorouracil for site-specific delivery to colon.
    Rai G; Yadav AK; Jain NK; Agrawal GP
    Drug Deliv; 2016; 23(1):328-37. PubMed ID: 24845476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of colon-specific pH and time-dependent flurbiprofen tablets.
    Vemula SK; Veerareddy PR; Devadasu VR
    Eur J Drug Metab Pharmacokinet; 2015 Sep; 40(3):301-11. PubMed ID: 24916715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, characterization and in vitro evaluation of 5-aminosalicylic acid loaded N-succinyl-chitosan microparticles for colon specific delivery.
    Mura C; Nácher A; Merino V; Merino-Sanjuán M; Manconi M; Loy G; Fadda AM; Díez-Sales O
    Colloids Surf B Biointerfaces; 2012 Jun; 94():199-205. PubMed ID: 22341520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three levels face centered central composite design of colon targeted micro-particulates system of celecoxib: screening of formulations variables and in vivo studies.
    Nandy BC; Verma V; Dey S; Mazumder B
    Curr Drug Deliv; 2014; 11(5):621-35. PubMed ID: 24844925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and characterization of colon specific drug delivery system bearing 5-ASA and Camylofine dihydrochloride for the treatment of ulcerative colitis.
    Dubey R; Dubey R; Omrey P; Vyas SP; Jain SK
    J Drug Target; 2010 Sep; 18(8):589-601. PubMed ID: 20088681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and characterization of free mixed-film of pectin/chitosan/Eudragit RS intended for sigmoidal drug delivery.
    Ghaffari A; Navaee K; Oskoui M; Bayati K; Rafiee-Tehrani M
    Eur J Pharm Biopharm; 2007 Aug; 67(1):175-86. PubMed ID: 17346954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chitosan oligosaccharide as prospective cross-linking agent for naproxen-loaded Ca-alginate microparticles with improved pH sensitivity.
    Čalija B; Milić J; Cekić N; Krajišnik D; Daniels R; Savić S
    Drug Dev Ind Pharm; 2013 Jan; 39(1):77-88. PubMed ID: 22339172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.